552 related articles for article (PubMed ID: 15065219)
1. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
2. Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors.
Hwang DR; Narendran R; Laruelle M
Bioconjug Chem; 2005; 16(1):27-31. PubMed ID: 15656572
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
Ginovart N; Wilson AA; Houle S; Kapur S
Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
[TBL] [Abstract][Full Text] [Related]
4. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
Narendran R; Mason NS; Laymon CM; Lopresti BJ; Velasquez ND; May MA; Kendro S; Martinez D; Mathis CA; Frankle WG
J Pharmacol Exp Ther; 2010 May; 333(2):533-9. PubMed ID: 20103586
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
Narendran R; Hwang DR; Slifstein M; Hwang Y; Huang Y; Ekelund J; Guillin O; Scher E; Martinez D; Laruelle M
J Pharmacol Exp Ther; 2005 Oct; 315(1):80-90. PubMed ID: 16014571
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
Seeman P
Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
McCormick PN; Kapur S; Reckless G; Wilson AA
Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
11. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
12. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
13. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
14. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
[TBL] [Abstract][Full Text] [Related]
15. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.
Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP
Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primate.
Narendran R; Slifstein M; Hwang DR; Hwang Y; Scher E; Reeder S; Martinez D; Laruelle M
Synapse; 2007 Feb; 61(2):106-9. PubMed ID: 17117423
[No Abstract] [Full Text] [Related]
17. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
18. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
[TBL] [Abstract][Full Text] [Related]
20. Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat.
Palner M; Kjaerby C; Knudsen GM; Cumming P
Neurochem Int; 2011 Feb; 58(3):243-7. PubMed ID: 21163313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
